Bio-Techne Corp
F:TE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bio-Techne Corp
F:TE1
|
US |
|
Plato Gold Corp
XTSX:PGC
|
CA |
|
Nano One Materials Corp
F:LBMB
|
CA |
|
U
|
Uniqa Insurance Group AG
PSE:UQA
|
AT |
|
F
|
First Helium Inc
F:2MC
|
CA |
Wall St Price Targets
TE1 Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for TE1 is 77.43 EUR with a low forecast of 67.28 EUR and a high forecast of 86.09 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TE1's stock price target?
Price Target
77.43
EUR
According to Wall Street analysts, the average 1-year price target for TE1 is 77.43 EUR with a low forecast of 67.28 EUR and a high forecast of 86.09 EUR.
What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 44%.
